• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缩小胰腺癌治疗结果的差距:深入探讨不可改变因素及其在治疗中的潜在应用

Closing the Disparity in Pancreatic Cancer Outcomes: A Closer Look at Nonmodifiable Factors and Their Potential Use in Treatment.

作者信息

Vick Alexis D, Hery Danielle N, Markowiak Stephen F, Brunicardi F Charles

机构信息

From the College of Medicine and Life Sciences, and.

Department of Surgery, College of Medicine and Life Sciences, University of Toledo, ProMedica Health System, Toledo, OH.

出版信息

Pancreas. 2019 Feb;48(2):242-249. doi: 10.1097/MPA.0000000000001238.

DOI:10.1097/MPA.0000000000001238
PMID:30629027
Abstract

OBJECTIVES

African Americans (AAs) have disproportionately higher incidence and lower survival rates from pancreatic cancer compared with whites. Historically, this disparity has been attributed to modifiable risk factors. Recent studies suggest that nonmodifiable aspects may also play an important role. We review these new contributions as potential targets for closing the disparity.

METHODS

A PubMed search was conducted to review studies of nonmodifiable elements contributing to pancreatic cancer disparities in AAs.

RESULTS

Several nonmodifiable risks are associated with the racial disparity in pancreatic cancer. SSTR5 P335L, Kaiso, and KDM4/JMJD2A demonstrate differential racial expression, increasing their potential as therapeutic targets. Many social determinants of health and their associations with diabetes, obesity, and the microbiome are partially modifiable risk factors that significantly contribute to outcomes in minorities. Barriers to progress include the low minority inclusion in research studies.

CONCLUSIONS

Genomics, epigenetics, the microbiome, and social determinants of health are components that contribute to the pancreatic cancer disparity in AAs. These factors can be researched, targeted, and modified to improve mortality rates. Closing the disparity in pancreatic cancer will require an integrated approach of personalized medicine, increased minority recruitment to studies, and advanced health care/education access.

摘要

目的

与白人相比,非裔美国人(AA)患胰腺癌的发病率高得不成比例,生存率却更低。从历史上看,这种差异一直归因于可改变的风险因素。最近的研究表明,不可改变的因素可能也起着重要作用。我们将这些新发现作为缩小差距的潜在目标进行综述。

方法

进行了一项PubMed搜索,以综述有关导致AA胰腺癌差异的不可改变因素的研究。

结果

几种不可改变的风险与胰腺癌的种族差异有关。SSTR5 P335L、Kaiso和KDM4/JMJD2A表现出不同的种族表达,增加了它们作为治疗靶点的潜力。许多健康的社会决定因素及其与糖尿病、肥胖症和微生物群的关联是部分可改变的风险因素,对少数群体的预后有重大影响。进展的障碍包括少数群体参与研究的比例较低。

结论

基因组学、表观遗传学、微生物群和健康的社会决定因素是导致AA胰腺癌差异的因素。可以对这些因素进行研究、靶向和修改,以提高死亡率。缩小胰腺癌的差距需要个性化医疗、增加少数群体参与研究以及扩大获得先进医疗保健/教育的机会等综合方法。

相似文献

1
Closing the Disparity in Pancreatic Cancer Outcomes: A Closer Look at Nonmodifiable Factors and Their Potential Use in Treatment.缩小胰腺癌治疗结果的差距:深入探讨不可改变因素及其在治疗中的潜在应用
Pancreas. 2019 Feb;48(2):242-249. doi: 10.1097/MPA.0000000000001238.
2
Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.美国胰腺癌发病率和死亡率的种族差异和趋势。
Clin Gastroenterol Hepatol. 2020 Jan;18(1):171-178.e10. doi: 10.1016/j.cgh.2019.05.059. Epub 2019 Jun 13.
3
Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.胰腺癌治疗中的种族差异及其对生存的影响:基于人群的分析。
J Cancer Res Clin Oncol. 2012 Apr;138(4):715-22. doi: 10.1007/s00432-012-1156-8. Epub 2012 Jan 15.
4
Racial and Socioeconomic Disparities in the Treatments and Outcomes of Pancreatic Cancer Among Different Treatment Facility Types.不同治疗机构类型的胰腺癌治疗和结局中的种族和社会经济差异。
Pancreas. 2020 Nov/Dec;49(10):1355-1363. doi: 10.1097/MPA.0000000000001688.
5
Pancreatic cancer disparities in African Americans.非裔美国人胰腺癌的差异
Pancreas. 2015 May;44(4):522-7. doi: 10.1097/MPA.0000000000000323.
6
Why do Black Americans have a higher risk of pancreatic cancer than White Americans?为什么美国黑人患胰腺癌的风险比美国白人高?
Epidemiology. 2003 Jan;14(1):45-54. doi: 10.1097/00001648-200301000-00013.
7
Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.胰腺神经内分泌肿瘤生存中的种族差异:一项监测、流行病学和最终结果(SEER)研究
Cancer Med. 2017 Nov;6(11):2745-2756. doi: 10.1002/cam4.1220. Epub 2017 Oct 4.
8
Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.治疗不公平和种族与胰腺导管腺癌生存的关联。
JAMA Surg. 2020 Feb 1;155(2):e195047. doi: 10.1001/jamasurg.2019.5047. Epub 2020 Feb 19.
9
Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities.2016 年非裔美国人癌症统计数据:减少种族差异方面的进展和机会。
CA Cancer J Clin. 2016 Jul;66(4):290-308. doi: 10.3322/caac.21340. Epub 2016 Feb 22.
10
Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review.非裔美国女性的健康差异与三阴性乳腺癌:综述。
JAMA Surg. 2017 May 1;152(5):485-493. doi: 10.1001/jamasurg.2017.0005.

引用本文的文献

1
Impact of Environmental Quality on Pancreatic Cancer Outcomes Post Pancreatoduodenectomy: A Retrospective Cohort Study.环境质量对胰十二指肠切除术后胰腺癌预后的影响:一项回顾性队列研究
J Gastrointest Cancer. 2025 May 31;56(1):126. doi: 10.1007/s12029-025-01254-4.
2
Health Inequities in Pancreatic Disorders in the Black/African American Community.黑人/非裔美国人社区胰腺疾病中的健康不平等现象。
J Racial Ethn Health Disparities. 2025 Mar 26. doi: 10.1007/s40615-025-02402-z.
3
Investigating Differences in Pancreatic Ductal Adenocarcinoma Mutational Profiles Across Racial and Ethnic Groups: A Lack of Diversity Clouds the Picture.
研究不同种族和族裔群体中胰腺导管腺癌突变谱的差异:缺乏多样性使情况变得模糊。
Ann Surg Oncol. 2024 Oct;31(10):6361-6363. doi: 10.1245/s10434-024-15589-y. Epub 2024 Jun 10.
4
Accessibility to ERCP-performing hospitals among patients with pancreatic cancer living in SEER regions.在 SEER 地区的胰腺癌患者中,可获得 ERCP 治疗的医院的情况。
Cancer Med. 2024 Feb;13(3):e7020. doi: 10.1002/cam4.7020.
5
Impact of Biopsy Attempts, Race, and Access on Time to Initiation of Treatment for Pancreatic Cancer.活检尝试、种族和可及性对胰腺癌治疗开始时间的影响。
J Gastrointest Surg. 2023 Nov;27(11):2474-2483. doi: 10.1007/s11605-022-05531-6. Epub 2023 Sep 22.
6
Socioeconomic Predictors of Access to Care for Patients with Operatively Managed Pancreatic Cancer in New York State.纽约州接受手术治疗的胰腺癌患者获得治疗的社会经济预测因素。
J Gastrointest Surg. 2022 Aug;26(8):1647-1662. doi: 10.1007/s11605-022-05320-1. Epub 2022 May 2.
7
Social determinants of health associated with poor outcome for rural patients following resected pancreatic cancer.与胰腺癌切除术后农村患者不良预后相关的健康社会决定因素。
J Gastrointest Oncol. 2021 Dec;12(6):2567-2578. doi: 10.21037/jgo-20-583.
8
The role of education on Cancer amenable mortality among non-Hispanic blacks & non-Hispanic whites in the United States (1989-2018).美国非西班牙裔黑人和非西班牙裔白人的教育对癌症可预防死亡率的作用(1989-2018 年)。
BMC Cancer. 2021 Sep 7;21(1):907. doi: 10.1186/s12885-021-08633-7.
9
Diversity and Inclusion in Pancreatic Cancer Clinical Trials.胰腺癌临床试验中的多样性与包容性。
Gastroenterology. 2021 Dec;161(6):1741-1746.e3. doi: 10.1053/j.gastro.2021.06.079. Epub 2021 Aug 17.
10
Racial Disparity and Social Determinants in Receiving Timely Surgery Among Stage I-IIIA Non-small Cell Lung Cancer Patients in a U.S. Southern State.美国南部一州 I 期-IIIA 期非小细胞肺癌患者及时接受手术的种族差异和社会决定因素。
Front Public Health. 2021 Jun 2;9:662876. doi: 10.3389/fpubh.2021.662876. eCollection 2021.